Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients: A systematic review of the literature with meta-analysis

Supportive Care in Cancer

Volumn 10, Issue 3, 2002, Pages 181-188

  Berghmans, Thierry ^a   Paesmans, M ^a   Lafitte, J J ^a   Mascaux, C ^a   Meert, A P ^a   Jacquy, C ^a   Burniat, A ^a   Steels, E ^a   Vallot, F ^a   Sculier, J P ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Febrile neutropenia; Granulocyte colony stimulating factor; Granulocyte macrophage colony stimulating factor; Neoplasms

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANTIBIOTIC THERAPY; CANCER PATIENT; CLINICAL TRIAL; DISEASE DURATION; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEVER; HOSPITALIZATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SUPERINFECTION;

ANTI-BACTERIAL AGENTS; FEVER; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LENGTH OF STAY; NEOPLASMS; NEUTROPENIA; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0036940885     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-001-0312-5     Document Type: Review

References (19)

1. Anaissie EJ, Vartivarian S, Bodey GP, Legrand C, Kantarjian H, Abi-Said D, Karl C, Vadhan-Raj S (1996) Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia [see comments]. Am J Med 100:17-23
2. Arnberg H, Letocha H, Nou F, Westlin JF, Nilsson S (1998) GM-CSF in chemotherapy-induced febrile neutropenia-a double-blind randomized study. Anticancer Res 18:1255-1260
3. Aviles A, Guzman R, Garcia EL, Talavera A, Diaz-Maqueo JC (1996) Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia. Anticancer Drugs 7:392-397
4. Biesma B, de Vries EG, Willemse PH, Sluiter WJ, Postmus PE, Limburg PC, Stern AC, Vellenga E (1990) Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever. Eur J Cancer 26:932-936
5. Bodey GP, Buckley MB, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340
6. Luce S, Paesmans M, Berghmans T, Castaigne C, Sotiriou C, Vermylen P, Scutier JP (1998) Randomized trials evaluating radiotherapy adjuvant to chemotherapy for small cell lung carcinoma (SCLC): qualitative evaluation before metaanalysis. The European Lung Cancer Working Party (ELCWP). Rev Mal Resp 15:633-641
7. Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I (1994) Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebocontrolled trial [see comments]. Ann Intern Med 121:492-501
8. Mascaux C, Paesmans M, Berghmans T, Branle F, Lafitte JJ, Lemaitre F, Meert AP, Vermylen P, Sculier JP (2000) A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. European Lung Cancer Working Party. Lung Cancer 30:23-26
9. Mayordomo JI, Rivera F, Diaz-Puente MT, Lianes P, Colomer R, Lopez-Brea M, Lopez E, Paz-Ares L, Hitt R, Garcia-Ribas I (1995) Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors [see comments]. J Natl Cancer Inst 87:803-808
10. Meert AP, Berghmans T, Branle F, Lemaitre F, Mascaux C, Rubesova E, Vermylen P, Paesmans M, Sculier JP (1999) Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment. Anticancer Res 19:4379-4390
11. Mitchell PL, Morland B, Stevens MC, Dick G, Easlea D, Meyer LC, Pinkerton CR (1997) Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients. J Clin Oncol 15:1163-1170
12. Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade JL III, Winn RJ, Wozniak AJ, Somerfield MR, for the American Society of Clinical Oncology Growth Factors Expert Panel (2000) 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 18:3558-3585
13. Ravaud A, Chevreau C, Cany L, Houyau P, Dohollou N, Roche H, Soubeyran P, Bonichon F, Mihura J, Eghbali H, Tabah I, Bui BN (1998) Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial [see comments]. J Clin Oncol 16:2930-2936
14. Riikonen P, Saarinen UM, Makipernaa A, Hovi L, Komulainen A, Pihkala J, Jalanko H (1994) Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebocontrolled study in children [see comments]. Pediatr Infect Dis J 13:197-202
15. Sculier JP, Ghisdal L, Berghmans T, Branle F, Lafitte JJ, Vallot F, Meert AP, Lemaitre F, Steels E, Burniat A, Mascaux C, Paesmans M, for the European Lung Cancer Working Party (2001) The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with metaanalysis of the literature. Br J Cancer 84:1150-1155
16. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F (2000) Methods for meta-analysis in medical research. Wiley, Chichester
17. Uyl-de Groot CA, Vellenga E, de Vries EG, Lowenberg B, Stoter GJ, Rutten FF (1997) Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial. Pharmacoeconomics 12:351-360
18. Vellenga E, Uyl-De Groot CA, de Wit R, Keizer HJ, Lowenberg B, ten Haaft MA, de Witte TJ, Verhagen CA, Stoter GJ, Rutten FF, Mulder NH, Smid WM, de Vries EG (1996) Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. J Clin Oncol 14:619-627
19. Yoshida M, Karasawa M, Naruse T, Fukuda M, Hirashima K, Oh H, Ninomiya H, Abe T, Saito K, Shishido H, Moriyama Y, Shibata A, Motoyoshi K, Nagata N, Miura Y (1998) Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group. Int J Hematol 69:81-88